News

Def Leppard guitarist Vivian Campbell has shared uplifting news about his health, revealing he is finally in remission from Hodgkin’s lymphoma after battling the disease for over a decade.
Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...
Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE ® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging bispecific antibody administered ...
Def Leppard guitarist Vivian Campbell reveals he’s in remission from Hodgkin lymphoma — 12 years after diagnosis By . Jacki Thrapp. Published June 14, 2025, 1:46 a.m. ET.
Speaking on SiriusXM’s Trunk Nation With Eddie Trunk, he said: “I’ve been very lucky, actually. I got an early diagnosis for Hodgkin’s lymphoma 13 years ago, 12 years ago, something like that.
A sound system for the people. Ozy’s vision for Flying Galvanize began with an unlikely muse: Jamaican sound system culture. That Do-It-Yourself, grassroots infrastructure—built from sweat ...
Alyssa Maria Wong Raj Kumar was adopted at the age of four and lived a comfortable life in a home filled with love, laughter, and plants. Outside the house was ...
A Phase 1 study for C-CAR039 was conducted in China for the treatment of patients with B-cell non-Hodgkin lymphoma (predominantly LBCL). 3 Johnson & Johnson is also evaluating the safety and ...
MILAN - Johnson & Johnson (NYSE:JNJ) reported Friday that its experimental dual-targeting CAR T-cell therapy demonstrated high response rates in patients with relapsed or refractory large B-cell ...
A Phase 1 study for C-CAR039 was conducted in China for the treatment of patients with B-cell non-Hodgkin lymphoma (predominantly LBCL). 3 Johnson & Johnson is also evaluating the safety and ...
Vivian Campbell announced that he had been diagnosed with Hodgkin’s lymphoma back in mid-2013. Naturally, this shocked his fans, as he had been touring with Def Leppard through the summer of 2013.